| Date | Company | Amount | Funding type | Investors | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2013-04-24 | Genticel (France) | € 18.2 million | fundraising | Wellington Partners (USA) IDInvest Partners (France) Edmond de Rothschild Investment Partners (EdRIP) (France) InnoBio fund (France) Amundi Private Equity Funds (France) | Infectious diseases - Gynecology - Women's health | Fundraising |
| 2013-04-24 | Galapagos (Belgium) | € 54 million | private placement | institutional investors in Europe and USA | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases | Private placement |
| 2013-04-22 | Curetis (Germany) | € 20 million | series B financing round | HBM Partners (Cayman Islands) aeris Capital (Switzerland) LSP Life Sciences Partners (The Netherlands) Forbion Capital (The Netherlands) BioMedInvest (Switzerland) Roche Venture Fund (Switzerland) CD Venture (Germany) KfW (Germany) Curetis’ management , several of the company\'s founders, private investors, board members | Infectious diseases | Fundraising |
| 2013-04-18 | Allecra Therapeutics (Germany - France) | €15 million | Series A financing round | Forbion Capital Partners (The Netherlands) Edmond de Rothschild Investment Partners (France) EMBL Ventures (Germany) | Infectious diseases | Fundraising |
| 2013-04-18 | Actogenix (Belgium) | € 10.7 million | series B financing round | Saffelberg Investments (Belgium) Gimv (Belgium) Biotech Fund Flanders (Belgium) Baekeland Fund (Belgium) BioVest (Belgium) LSP Life Science Partners (The Netherlands) Aescap Venture (The Netherlands) Ventech (France) | Fundraising | |
| 2013-04-17 | Rodos BioTarget (Germany) | € 2.6 million | InvestImpuls-Fonds of the region of Hannover | Cancer - Oncology - Infectious diseases | Fundraising | |
| 2013-04-16 | Auris Medical (Switzerland) | CHF 47.1 million (€38.7 million) | Series C financing round | Sofinnova Ventures (USA) Sofinnova Partners (France) | Otorhinolaryngology | Fundraising |
| 2013-04-15 | Avilex Pharma (Denmark) | undisclosed | seed funding | Novo Seeds (Denmark) | CNS diseases - Neurological diseases | Fundraising |
| 2013-04-12 | Neuronax (France) | 150 k€ | crowdfunding | WiSEED investors community | CNS diseases | Fundraising |
| 2013-04-12 | Genfit (France) | € 14.325 million | private placement | Cardiovascular diseases - Metabolic diseases - Liver diseases | Private placement | |
| 2013-04-10 | BerGenBio (Norway) | NOK 13 million (€1.5 million) | grant | Cancer - Oncology | Grant | |
| 2013-04-09 | MedDay (France) | € 8 miillion | InnoBio (France) Sofinnova Partners (France) | Neurodegenerative diseases - Metabolic diseases | Fundraising | |
| 2013-04-09 | Theradiag (France) | €1.2 million | grant | OSEO (France) | Diagnostic - Infectious diseases | Grant |
| 2013-04-08 | Canbex Therapeutics (UK) | £2.1 million (€2.45 million) | financing round | Merck Serono Ventures (Germany) UCL Business (UK) the Wellcome Trust (UK) | Neurodegenerative diseases | Fundraising |
| 2013-04-08 | GenSight Biologics (France) | € 32 million | series A financing round | Abingworth (UK) - Index Ventures (USA-Switzerland) - Versant Ventures (Switzerland) - Novartis Venture Fund (Switzerland) | Ophtalmological diseases | Fundraising |
| 2013-03-19 | Addex Therapeutics (Switzerland) | $ 1 million (€ 0.77 million) | grant | The Michael J. Fox Foundation - MJFF (USA) | Neurodegenerative diseases | Grant |
| 2013-03-19 | Hybrigenics (France) | € 0.6 million | grant | Neurodegenerative diseases | Grant | |
| 2013-03-11 | Progenitor Labs (UK) | £4 million (€2.7 million) | seed financing | SR One (UK) | Regenerative medicine | Establishment of a new subsidiary in the EU |
| 2013-03-11 | Oncodesign (France) | € 13.4 million | grant | Investing for the Future program (France) | Cancer - Oncology | Grant |
| 2013-03-11 | Reneuron (UK) | £1.2 million | grant | Biomedical Catalyst Fund (UK) | Rare diseases - Ophtalmological diseases | Grant |
